Physician profile
Adam Lipman
NPI 1215170808
$12,026.57
in general payments reported to CMS, 2019-2025
33 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,346 · 2020: $657 · 2021: $1,908 · 2022: $1,787 · 2023: $649 · 2024: $1,429 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,250 · Travel and Lodging: $79.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,250.00 |
| Travel and Lodging | $79.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $5,973.07 | 2019-2024 | |
| Stryker Corporation | $2,332.85 | 2019-2025 | Mako, Insignia, Matta |
| Smith+Nephew, INC. | $751.58 | 2019-2025 | Evos Mini, Real Intelligence, Lens 4k |
| Depuy Synthes Sales INC. | $536.01 | 2019-2024 | Monovisc, Truespan Orthocord, Orthovisc |
| Horizon Therapeutics Plc | $441.64 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $288.15 | 2019-2025 | Comprehensive Shoulder System, Tricera Handpiece |
| Heron Therapeutics, INC. | $279.84 | 2022-2025 | Zynrelef, Aponvie |
| Si-Bone, INC. | $179.56 | 2019-2022 | |
| Vericel Corporation | $151.85 | 2024 | Maci |
| Bioventus LLC | $144.45 | 2019-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System |
| Djo, LLC | $138.65 | 2020-2025 | Cmf |
| Ethicon US, LLC | $95.60 | 2019-2024 | Vistaseal |
| Embody, INC. | $95.00 | 2022 | |
| Orthofix Medical, INC. | $80.33 | 2019-2025 | Physio-Stim |
| Carbofix Orthopedics INC | $78.72 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $72.13 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $48.57 | 2023 | |
| Ferring Pharmaceuticals INC. | $32.86 | 2022 | |
| Electronic Waveform Lab, INC. | $27.69 | 2025 | |
| Illuminoss Medical, INC. | $26.06 | 2025 | Photodynamic Bone Stabilization Procedure Pack |
| Davol INC. | $25.70 | 2021 | |
| Curonix LLC | $24.31 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Acell, INC. | $23.22 | 2020 | |
| Solventum Corporation | $22.51 | 2025 | Prevena |
| Pacira Therapeutics, INC. | $21.28 | 2019 | |
| Zyla Life Sciences, INC. | $20.81 | 2019 | |
| Nalu Medical, INC. | $20.72 | 2023 | Nalu Neurostimulation System |
| Abbott Laboratories | $18.49 | 2024 | Eterna |
| Biedermann Motech, INC. | $16.59 | 2021 | |
| Ermi LLC | $15.69 | 2019 | |
| Nevro Corp. | $15.68 | 2024 | Senza |
| Olympus America INC. | $14.88 | 2024 | Evis X1 Video System Center |
| Convatec INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Lipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.